DAVIDSON MICHAEL H. (Chief Executive Officer) sold 71.8% of their position (443.71K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market sale worth $14.75M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2026ACC: 0001193125-26-085947
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-443.71K
Net shares
Net seller
$14.75M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
443.71K acquired · 887.41K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+443.71K
Price / share
—
Trade value
—
% of position
254.8%
3/2/2026
174.14K→617.85K
Ordinary Shares
Direct
Shares
−443.71K
Price / share
$33.25
Trade value
$14.75M
% of position
71.8%
3/2/2026
617.85K→174.14K
Total
Net shares
+0.00
Net value
-$14.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/2/2026 | M · Option Exercise | +443.71K | — | — | 254.8% | 174.14K | 617.85K |
| Ordinary Shares Direct | 3/2/2026 | S · Sale | −443.71K | $33.25 | $14.75M | 71.8% | 617.85K | 174.14K |
| Total | +0.00 | -$14.75M | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Ordinary Shares
443.71K shares
Shares
−443.71K
Strike price
Held after
239.27K
Exercisable
—
3/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares443.71K shares | 3/2/2026 | M · Option Exercise | −443.71K | — | 239.27K |